Detalles de la búsqueda
1.
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med
; 21(3): e1004360, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38502656
2.
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
N Engl J Med
; 384(12): 1089-1100, 2021 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761206
3.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
N Engl J Med
; 384(11): 1003-1014, 2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33730454
4.
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
Lancet
; 399(10330): 1141-1153, 2022 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35305740
5.
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
PLoS Med
; 19(6): e1004024, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35727802
6.
Knowledge, attitudes, and perceptions of long-acting reversible contraceptive methods among healthcare workers in sub-Saharan Africa.
Trop Med Int Health
; 26(8): 840-861, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33848393
7.
Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa.
BMC Health Serv Res
; 21(1): 305, 2021 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33823842
8.
Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study.
N Engl J Med
; 385(6): 570-571, 2021 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34077639
9.
Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa.
J Antimicrob Chemother
; 72(11): 3141-3148, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28981637
10.
Etiology and antimicrobial susceptibility of pathogens responsible for urethral discharge among men in Harare, Zimbabwe.
Sex Transm Dis
; 41(12): 713-7, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25581806
11.
Quabodepistat in combination with delamanid and bedaquiline in participants with drug-susceptible pulmonary tuberculosis: protocol for a multicenter, phase 2b/c, open-label, randomized, dose-finding trial to evaluate safety and efficacy.
Trials
; 25(1): 70, 2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243296
12.
Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.
Pan Afr Med J
; 46: 74, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38282767
13.
Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study).
BMJ Med
; 2(1): e000302, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37063238
14.
Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa.
J Antimicrob Chemother
; 72(11): 3222, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961961
15.
Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
J Neurovirol
; 18(3): 162-71, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22528477
16.
Clinical correlations to distinguish severe from milder forms of obstructive sleep apnoea syndrome using overnight oximetry for prioritising adenotonsillectomy in a limited-resource setting.
Int J Pediatr Otorhinolaryngol
; 152: 110988, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34871949
17.
Allergic reactions to the Ad26.COV2.S vaccine in South Africa.
J Allergy Clin Immunol Glob
; 1(1): 2-8, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37780073
18.
Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials.
J Acquir Immune Defic Syndr
; 89(4): 405-413, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34923559
19.
Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making.
South Afr J HIV Med
; 22(1): 1246, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34230861
20.
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings.
J Acquir Immune Defic Syndr
; 87(1): 680-687, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587510